Board of Trustees

The members of the OxHA Board of Trustees, and OxHA’s coordinating director, are listed below.

Chair of the Board

Sir John Bell
Regius Professor of Medicine University of Oxford

Sir John has been Nuffield Professor of Clinical Medicine, University of Oxford, since 1992, and was elected Regius Professor of Medicine in 2002. He took up the post of President of the Academy of Medical Sciences in November 2006.

He is a fellow of Magdalen College and is also a fellow of the Royal College of Physicians, London. He was a Rhodes Scholar at Magdalen College, Oxford, from 1975 to 1978 and did his postgraduate work in Oxford and London. He was Clinical Fellow in Immunology at Stanford University from 1982 to 1987. In 1987 he returned to Oxford on a Wellcome Senior Clinical Fellowship in the Nuffield Department of Clinical Medicine.

Sir John has directed research programmes in immunology and genetics that have identified genes involved in diabetes and rheumatoid arthritis. He was a cofounder of the Wellcome Trust Centre for Human Genetics in Oxford. His administrative responsibilities include the Nuffield Department of Clinical Medicine, the largest biomedical research department in the United Kingdom.

Members of the Board

Professor David Matthews – Executive director
Vice Principal of Harris Manchester College Oxford

David Matthews is currently Professor of Diabetes Medicine, University of Oxford, and is Vice Principal of Harris Manchester College, Oxford. His academic research interests include mathematical modelling of insulin resistance, homeostatic model assessment of beta-cell function and insulin resistance, ketones, and therapeutic agents in type 2 diabetes. An emerging and vital concern has been the global obesity epidemic – and the pandemic of diabetes. He was a founding trustee of the Oxford Health Alliance and was the Director of the Global Alliance for Chronic Disease; a world-wide association of eight research councils collaborating in the fight against Chronic Disease. His is Co-Director of the UK Diabetes Research Network. He has authored more than 230 publications and is on the editorial boards of several professional journals.

Grace Vanterpool MBE

Consultant Nurse Diabetes

Grace has been nursing for 33 years, working as a diabetes specialist nurse for19 years and a consultant nurse in diabetes for 6 years.  She works across sectors in secondary care at Imperial College, London and in primary care at the Central London Community Health NHS Trust. She has published her work and holds lectureships at two universities.  Grace has received several awards for her services to diabetes, nursing and ethnic minorities including the NHS and Kings Fund Champions Award Services to diabetes patients in 2003, the Chief Executive Award (Thames Valley) for work done over and above the call of duty in 2004, the Community Nurse of the Year in 2005 and in 2006 she was awarded the Nurse of the Year, an award for innovations and improving the health of Black and minority Ethnic groups and the MBE. Grace chairs the RCN diabetes forum and is a co-chair of TREND Training Research  Education Nurses in Diabetes . She sits on the All Parliamentary Group for diabetes and is co-chair of the education task and finish group at Diabetes UK. She represents the Black and minority Ethnic groups on the Diversity Forum at Central London Community Health NHS Trust with the aim of ensuring that policies and issues around diversity are addressed.

Professor Stephen MacMahon

Principal Director, The George Institute for Global Health

Steve MacMahon co-founded The George Institute at the University of Sydney in 1999 with the aim of establishing programs of research focused on chronic disease in resource-poor settings world-wide. The Institute has now become a global non-governmental not-for-profit organization with more than 300 members of staff across five research facilities in Australia, China, India and the UK. In addition to research, the Institute has established a large teaching and training facility at the University of Sydney, with many fellows from low and middle-income countries.

Steve MacMahon holds a personal chair in the Sydney Medical School with a particular interest in the prevention of vascular and renal complications of type 2 diabetes.  He was the founder and chief investigator of ADVANCE, the largest-ever randomized trial among people with type 2 diabetes. In 2008, he received the premier national award in Australia for research achievement  on the causesl prevention and treatment of cardiovascular diseases.